Prisons contain individuals at high risk of mv infection, notably through intravenous drug use. For complex political, socialand legal reasons penal institutions in the UK are unable to provide condoms and clean needles. The outbreak of HIV and hepatitis B that occurred in a Scottish prison in 1993 focused attention on the potential problems. Debate about the issue is hampered by a lack of useful information. Current data about risk behaviour and seroprevalence is reviewed, and compared with experience in other countries. Injecting drug use in prison appears to be common, and the majority who inject in prison share equipment, which can be used many times. Sexual activity may be a smaller risk factor, but does occur between men in prison. In addition, prisoners appear to have high rates of partner change between sentences. The true prevalence of HIV in UK prisons is difficult to assess, but the available data suggest it is between 0.1 and 4.5%, lower than in Southern Europe and the USA. A window of opportunity still exists to prevent further outbreaks of HIV in UK penal institutions and to maintain these low prevalence rates. Strenuous, and possibly unpalatable measures are needed now.
behaviour in UK prisons, HIV prevalence, evidence of transmission within prison, and make general recommendations to decrease the risk of a repeat of the Glenochil experience.
DRUG USE AND NEEDLE SHARING
In the UK there are an estimated 75,000-150,000 IDUs with a dramatic rise in prevalence in the 1980s 7 • Estimates of injecting drug use amongst prison inmates have varied considerably, in part reflecting differences in study design.
Interviews of random samples of prisoners in 1988-1989 by Maden, et al. revealed evidence of regular stimulant and opiate use in 10% of mens an~25% of women? before detention in English pnsons. There was however no available data on drug l;1se in prison. Studies interviewing lOUs attendmg needle exchange schemes in Scotland in~icated that 20-25% continued to inject in prison Wl~aPf-roximately 50% of these sharing needles in prison! -11. Furthermore 69% of lOUs had been in prison at least once and there was a disturbingly significant association between the number of custodial sentences and risk of being HIV positive. A similar survey, among previously imprisoned IDUs in London, found that 66% admitted to injecting in prison with 52% sharing needlesl-a INTRODUCTION Fo! a long time there have been repeated calls to the pnson service to introduce measures to decrease the risks of transmission of HIV and other blood borne yirus~s in UK prisons l -5 • Strang, et al. 4 in 1991 Identified a window of opportunity for preventing the spread of HIV within prison. Despite this therẽ as a.documented outbreak of hepatitis Band HIV infectIOn at Glenochil prison, Scotland, in 1993 6 • er~is little doubt that significant numbers of high risk mdividuals pass through the prison service, not~bly intravenous drug users (lOUs). For complex SOCIal, political and legal reasons penal institutions are u~able to provide condoms and clean needles for pnson inmates, in contrast to the situation in the COmmunity where there is ready access to condoms ?nd needle exchange schemes. A further problem 15 that most of the data derives from Scottish prisons nd there is still a lack of information about prisons In other parts of the UK. In addition most of the research has focused on male institutions and rn~le homosexual behaviour in prisons. In this article we review the available evidence about risk Corr.espondence to: Dr Simon P Curtis, Department of emtourinary Medicine, The Radcliffe Infirmary NHS Trust, oodstock Road, Oxford 0X2 6HE, UK finding consistent with other results-', This is of particular interest as whilst most data comes from Scotland, it supports the view that behaviour is likely to be similar in prisons elsewhere in the UK. These studies can be criticized because the information has been obtained outside custody and may not reflect current behaviour patterns. At HMP Saughton in Scotland, Dye and Isaacs questioned a sample of current inmates. Only 32% of the eligible prison population took part. They found that 35% of inmates had injected drugs, 67% of whom injected in prison and of these 76% shared needles in prisons'. Short-term and remand prisoners were significantly more likely to inject in prison. The best available data comes from a series of anonymous HIV surveillance studies with linked risk factor questionnaires, amongst current inmates, performed by independent investigators 1s-17. In the first such study, again at HMP Saughton'", 75% of the inmates took part: 18% of participants were IDUs, of whom approximately 50% injected in prison. A similar study at Polmont young offenders institution (Scotland), recruited 99% of inmates with 17% admitting previous injecting drug use, and 25% of these continuing to inject in prison>, A return visit to HMP Saughton in 1992 only had a 50% participation rate, but unchanged results with 17% mus of whom 40% had injected in prison". A recent study at HMP Glenochil, where there was an outbreak of HIV infection in 1993, has shown higher levels of drug use than at HMP Saughton (G Bird, personal communication). There were no data on needle sharing in these Scottish studies. To date there has only been one such study in England, at liMP Bullingdon (Curtis, etal. unpublished data).
In this study the findings were similar to the Scottish experience.
The risk of HIV spread depends on the background prevalence and patterns of needle use, including frequency of use and attempts to clean equipment. Interviews with ex-inmates attending a needle exchange estimated that the number of people sharing one needle in prison varied between 5 and 100 10 • Pickering, et al. interviewed 6 inmates in detail about their injecting equipment and its use in prison18. They obtained information about 11 sets of injecting equipment, over half of which were brought in by visitors. Of these 11 sets, 9 were shared with a mean of 9.4 injections per set. In a 5-day period one set was used by 7 individuals in 4 different areas of the prison. The sets were also shared freely between inmates in the same area, or exchanged for cigarettes or cannabis. Equipment was generally rinsed with water between injections, but on some occasions the contents of the same needle were shared. The Centre for Research on Drugs and Health Behaviour estimate that the average number of times that needles are shared in prison is 12 13 • In summary injecting drug use and needle sharing in UK prisons appears to be common, with estimates of between 21% and 66% of mus injecting in prison, of whom 43-76% share needles. These differences can largely be explained by differing methods of data collection. The anonymous surveillance studies 1S -17, which have similar designs, show remarkable consistency, with 17-20% of the prison sample being IDUs, of whom 40-58% inject in prison. These studies provide good independent data, but further work needs to be done in prisons throughout the UK to validate the consistency of these findings.
SEXUAL ACTIVITY
It is often assumed that sexual activity in prison is relatively common. Some prison officers believe that up to 60% of inmates engage in homosexual acts 19. The Prison Reform Trust carried out a survey of homosexual sex in prisons in England and Wales in 1988. They estimated that 20-30% of long-term prisoners may be involved in sexual activity with other prisoners at some time 20 22 suggest that 12% of inmates engage in anal intercourse at least once during a sentence, and in the USA23,24 22-33% of inmates are sexually active. It is not clear why the UK surveys report lower than expected rates of sexual activity. It seems unlikely to be due to fear of disciplinary action, as participants in these surveys readily admit to illicit drug use. It is more likely to be due to personal and social taboos regarding homosexuality, particularly as many men who have sex with men in prison may not consider themselves homosexual. Nonetheless it is clear that sexual activity in prison does exist, and outbreaks of sexually transmitted diseases in prisons have been reported 2s,26. This obviously has implications not only for HIV spread, but for other sexually transmitted diseases including hepatitis B25 and C27,28.
In addition to sexual activity within prison, there are data indicating that inmates are highly sexually active before imprisonment, and between prison stays. A study in London of ex-prisonersl-found that between periods in custody heterosexual men had a mean of 8 partners, and homosexual men a mean of 6. At HMP Saughton'P 59% of inmates had had 2-5 partners in the year before their sentence, with 15% having more than 6. In a young offenders institutionl", the figures were even higher. Clearly inmates can acquire and transmit sexually transmitted disease in and out of prison, particularly if they are frequently resentenced, which is a common pattern for IDUSll.
HIV PREVALENCE
The true HIV prevalence in UK prisons is difficult to estimate. In 1987 Harding! reported a survey of 17 European countries performed for the Council of Europe. Harding estimated the overall seroprevalence for European member states to be 10%, but with wide variation. He estimated Switzerland to have 11% seroprevalence, France 12.6%, The Netherlands 11%, Italy 16.8% and Spain 26%. England and Wales reported an extremely low ate of 0.1%. Interpretation of this report however IS difficult because specific methods were not reported, and, whilst in some countries seroprevalence was very high, case rates reported in the same paper were very low. Similar figures for the l!K.have been reported elsewhere's, Official data is limited because inmates may be reluctant to reveal their HIV positive status to the prison authorities, and likewise to have HIV tests performed through the prison medical service. Inmates who are known to be HIV positive have fears about segregation, br~ach of confidentiality and prejudice from other prIsoners. The Prison Reform Trust report serious breaches of confidentiality, with disastrous consequences for the individual/", The Home Office is currently carrying out voluntary, anonymous, confidential seroprevalence studies on new arrivals at prison. Compliance with these s.tudies is likely to be low as new arrivals are less likely to be co-operative and may mistrust the a.uthorities. It is a widely held view that official f~gures of the number of HIV-positive inmates are likely to be an underestimate" whatever method is used.
Retrospective data from ex-prisoners is available from independent researchers. In 1992 Turnbull, et al, recruited 452 ex-prisoners in England within 3 months of their release-". The sample was not randomly selected, but included men and women, and was similar to the general prison population in terms of the proportion of remand (20%) and sentenced inmates. with informed consent30. Saliva testing was used to maximize compliance and all these studies were also designed to provide linked risk factor information in line with the WHO recommendations'". At HMP Saughton there was a 4.5% HIV prevalence rate, with 75% of inmates participating, against a known background rate of 3.6% in the prison15. The prison rate is clearly dependent on the background community seroprevalence, which amongst Edinburgh IDUs at this time was high. Other studies with relatively high participation have shown prevalence rates of less than 1%16. These studies can however be criticized as non-participants are likely to be more at risk, or may know that they are HIV positive, and not believe in either the independence or the anonymity of the study. It is recognized that fear of random drug testing may discourage inmates from volunteeringv, and recent announcements by the Home Office that this is to be introduced may reduce participation in future studies. With all these studies the results from one institution cannot be extrapolated to another because of national variation in prevalence rates amongst background populations, particularly mus. This emphasizes the need for more of these studies to be performed in penal institutions throughout the UK.
An additional advantage of the voluntary HIV surveillance studies is that they increase HIV awareness within the prison, and enhance health promotion both for staff and inmates. They may also lead to a substantial increase in requests for named confidential testing, which has previously had a poor uptake 17 ,32. Of ex-prisoners interviewed who have had a confidential HIV test in prison, 36% found it an unpleasant experience, 17% reported not having the test voluntarily and 55% received no counselling33. Whilst these data need to be interpreted with caution, they provide an insight into why inmates are reluctant to have tests, and why the recent increase in trained HIV counsellors in the prison system is to be welcomed". However the study at HMP Bullingdon (Curtis, etal. unpublished data) generated approximately 100 requests for named, confidential testing outside the prison counselling service. This suggests that prisoners might be more likely to take up HIV testing if offered by an outside agency such as a visiting genitourinary medicine (GUM) service.
Apart from Australia, published prevalence rates in prisons overseas are generally higher. Data from Australia reports a 1.4% HIV prevalence rate in South Australian prtsons-', which is not too surprising in view of the relatively low rate of HIV positivity amongst high risk groups relative to other nations 34 • In the USA, in Maryland, data has come from blinded surveys at intake with rates of 7% in 1985 35 repeated annually and demonstrating a rising prevalence-s. As in the UK, however, the incidence will reflect that in the background community. It is not surprising therefore that a New York prison reported a much higher prevalence of 
HIV TRANSMISSION IN PRISON
There has been only the one documented outbreak of HIV infection in a UK prison5.6, but it is clear from the data presented that the potential for HIV spread to occur within prisons exists, and is perhaps greater than outside prison. There is also anecdotal evidence that HIV transmission within prison may have occurred elsewherel-19. There is already evidence of intra-prison transmission in the USA35,41,42. Two prospective transmission studies, have indicated little or no transmission, but there was a low background prevalence rate of only 1% and inadequate follow Up43,44. If the prison HIV testing service does not have the confidence of the inmates, HIV acquired in prison may remain undiagnosed until long after release with the potential for unwitting spread into the local community. Awareness of seroconversion illness needs to be high among prison medical staff, and inmates should have ready access to independent medical care through visiting GUM services so that they can have confidence in requesting HIV tests.
PREVENTION POLICIES
The prison service has already invested heavily in HIV education and counselling, and initiated research projects to investigate risk behaviour and the prevalence of HIV infection among Inmates". All inmates are supposed to be offered HIV testing and counselling, and prison officers who volunteer have been trained as counsellors. Some, but not all, prisons offer condoms to prisoners being released or on leave, and there are anecdotal reports of some prisons in Scotland making bleach tablets and condoms available. Education, however laudable, is not enough. Despite the recommendations of the WH031 inmates in most prisons in the UK do not have access to condoms and cleaning methods for equipment and needles. It is a widely held belief that provision of condoms might encourage sexual behaviour in prison despite the lack of data to support this. This can cause confusion when outside prison the emphasis is on promoting safer sex and risk reduction. There is sufficient data to prove that sexual activity does occur in prison and more thought should be given to resolving the ethical .dilemma of not providing condoms. Reducing the risks for drug users is complex. The fact that drug use in some prisons is common, suggests ready availability. This allows IOUs to continue their habit in prison and, more disturbingly, it was also apparent during the follow-up from the HMP Bullingdon study, that some inmates have become injecting drug users since incarceration (Sue Trotter, verbal communication). Random drug testing may reduce the use of illicit drugs in prison. Many inmates report inadequate drug detoxification regimens. Adequate methadone replacement, with drug rehabilitation programmes, in all prisons might decrease the necessity for many inmates to inject. Needle exchange schemes in prison could pose dangers to other inmates and prison staff but the provision of sterilizing equipment, such as bleach tablets, would go some way to decreasing risk.
Pressure is mounting on politicians from health professionals3--5,45 and support organizations 46 to act. It remains a fact that British prisoners have contracted HIVinfection whilst in custody, and more will do so unless a coherent prevention policy, which incorporates the provision of sterilizing equipment, condoms and adequate drug detoxification regimens are introduced. This should also include the continued funding of independent surveillance studies. The UK appears to be fortunate in that the HIV prevalence rate in penal institutions appears to be low. Strenuous and possibly unpalatable measures are needed to maintain this position.
